Growth Metrics

UL Solutions (ULS) Accumulated Expenses (2023 - 2026)

Quarterly results put Accumulated Expenses at $188.0 million for Q1 2026, up 14.63% from a year ago — trailing twelve months through Mar 2026 was $188.0 million (up 14.63% YoY), and the annual figure for FY2025 was $282.0 million, up 11.02%.

UL Solutions has reported Accumulated Expenses over the past 4 years, most recently at $188.0 million for Q1 2026.

  • Accumulated Expenses reached $188.0 million in Q1 2026 per ULS's latest filing, down from $282.0 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $282.0 million in Q4 2025 and bottomed at $164.0 million in Q1 2025.
  • Median Accumulated Expenses over the past 4 years was $215.5 million (2024), compared with a mean of $219.5 million.
  • The largest annual shift saw Accumulated Expenses decreased 9.61% in 2024 before it increased 21.64% in 2025.
  • Over 4 years, Accumulated Expenses stood at $281.0 million in 2023, then decreased by 9.61% to $254.0 million in 2024, then grew by 11.02% to $282.0 million in 2025, then plummeted by 33.33% to $188.0 million in 2026.
  • Business Quant data shows Accumulated Expenses for ULS at $188.0 million in Q1 2026, $282.0 million in Q4 2025, and $254.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Relx 81.40 Bn 81.16 Bn -
2 Rentokil Initial 79.56 Bn 78.10 Bn -
3 Cintas 69.26 Bn 69.08 Bn 1.45 Bn
4 Copart 33.09 Bn 28.01 Bn 971.24 Mn
5 UL Solutions 20.56 Bn 20.32 Bn 381.00 Mn
6 Global Payments 19.88 Bn 14.69 Bn 1.70 Bn
7 Rb Global 19.08 Bn 18.89 Bn 869.50 Mn
8 Aramark 13.57 Bn 13.16 Bn 426.35 Mn
9 Amentum Holdings 5.65 Bn 5.74 Bn 345.00 Mn
10 Dolby Laboratories 5.15 Bn 4.56 Bn 350.90 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 188.00 Mn
Dec 31, 2025 282.00 Mn
Sep 30, 2025 254.00 Mn
Jun 30, 2025 208.00 Mn
Mar 31, 2025 164.00 Mn
Dec 31, 2024 254.00 Mn
Sep 30, 2024 223.00 Mn
Jun 30, 2024 171.00 Mn
Mar 31, 2024 170.00 Mn
Dec 31, 2023 281.00 Mn